Clinical trials in cancer prevention

Area of Science:

• Oncology
• Preventive Medicine
• Clinical Research

Background:

• Cancer prevention research integrates laboratory, epidemiologic, and clinical trial methodologies.
• Clinical trials are crucial for validating promising leads from preclinical research.
• Evidence-based cancer prevention strategies require rigorous evaluation in human subjects.

Purpose of the Study:

• To investigate the necessity and role of clinical trials in cancer prevention.
• To outline the aims of National Cancer Institute-supported clinical prevention trials.
• To evaluate interventions for reducing cancer incidence, progression, and mortality.

Main Methods:

• Conducting clinical trials to test interventions identified through laboratory and epidemiologic research.
• Evaluating interventions such as dietary modifications (low-fat diet) and specific agents (beta carotene, retinoids, vitamins).
• Assessing outcomes including reversal of precursor lesions, prevention of malignancy, and reduction in cancer/overall mortality.

Main Results:

• Clinical trials provide essential data on intervention efficacy and safety.
• They quantify participant acceptance and address risk/benefit ratios.
• The National Cancer Institute has established a program for clinical cancer prevention trials.

Conclusions:

• Clinical trials are indispensable for translating cancer prevention discoveries into practice.
• Positive clinical trial results support population-wide application of preventive measures.
• Ongoing trials explore diverse interventions to combat cancer effectively.